Holen Sie sich die Stockscreener-App
0.92
2.65%
-0.025
Schlusskurs vom Vortag:
$0.945
Offen:
$0.95
24-Stunden-Volumen:
40,696
Relative Volume:
0.91
Marktkapitalisierung:
$3.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+12.20%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.86
$0.97
1-Wochen-Bereich:
$0.77
$1.0594
52-Wochen-Spanne:
$0.77
$1.51
Polyrizon Ltd Stock (PLRZ) Company Profile
Vergleichen Sie PLRZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| PLRZ | 0.92 | 3.78M | 0 | 0 | 0 | 0.00 |
| VRTX | 450.43 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 749.43 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.59 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.65 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.86 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Polyrizon Ltd Aktie (PLRZ) Neueste Nachrichten
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ) - Quantisnow
PLRZPolyrizon Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Polyrizon Announces Closing of $4.2 Million Initial Public Offering - The Manila Times
Polyrizon Prices 958.9K Share IPO at $4.38/unit By Investing.com - Investing.com South Africa
Polyrizon Prices 958.9K Share IPO at $4.38/unit - Investing.com
Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker 'PLRZ” - The Manila Times
Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ” - StockTitan
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million - GlobeNewswire
Israel-Based Biotech Penny Stock SciSparc Outlicenses Its Cannabinoid Pain Therapy - Benzinga
SciSparc signs exclusive patent license agreement with Polyrizon - TipRanks
SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million - GlobeNewswire
Israeli biotech Polyrizon discloses terms for proposed $19M US IPO (NASDAQ:MDGS) - Seeking Alpha
Finanzdaten der Polyrizon Ltd-Aktie (PLRZ)
Es liegen keine Finanzdaten für Polyrizon Ltd (PLRZ) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):